{
  "@type": "NewsArticle",
  "identifier": "2022--08--21--en--myfeed--HackerNews--NewsArticle--32541018",
  "url": "https://news.ycombinator.com/item?id=32541018",
  "headline": "What's behind the FDA's controversial strategy for evaluating new COVID boosters",
  "publisher": {
    "@type": "Organization",
    "name": "HackerNews",
    "url": "https://news.ycombinator.com",
    "logo": "https://hn.buzzing.cc/avatar.png"
  },
  "description": "",
  "keywords": [],
  "author": {
    "@type": "Person",
    "name": "whitepoplar",
    "url": "https://news.ycombinator.com/user?id=whitepoplar"
  },
  "discussionUrl": "https://news.ycombinator.com/item?id=32541018",
  "sameAs": "https://www.npr.org/sections/health-shots/2022/08/18/1117778748/whats-behind-the-fdas-controversial-strategy-for-evaluating-new-covid-boosters",
  "dateCreated": "2022-08-21T15:26:44.568Z",
  "datePublished": "2022-08-21T15:19:02.000Z",
  "dateModified": "2022-08-21T15:26:44.568Z",
  "interactionStatistic": [
    {
      "@type": "InteractionCounter",
      "interactionType": {
        "@type": "LikeAction"
      },
      "userInteractionCount": 4
    },
    {
      "@type": "InteractionCounter",
      "interactionType": {
        "@type": "CommentAction"
      },
      "userInteractionCount": 0
    }
  ],
  "headline_zh-Hans": "美国食品和药物管理局评估新的COVID助推器的争议性策略背后是什么？\n",
  "headline_zh-Hant": "美國食品和藥物管理局評估新的COVID助推器的爭議性策略背後是什麼？\n",
  "@context": [
    "https://schema.org",
    {
      "@vocab": "http://schema.org/",
      "@language": "en",
      "headline_zh-Hans": {
        "@id": "headline",
        "@language": "zh-Hans"
      },
      "headline_zh-Hant": {
        "@id": "headline",
        "@language": "zh-Hant"
      },
      "@version": 1.1
    }
  ]
}